The DOI matches its Crossref record; 290 of the 290 references it cites were found in a registry or an index.
Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐ and metastasis‐initiating cells
Open accessAbstract
Accumulating lines of experimental evidence have revealed that hypoxia‐inducible factors, HIF‐1α and HIF‐2α, are key regulators of the adaptation of cancer‐ and metastasis‐initiating cells and their differentiated progenies to oxygen and nutrient deprivation during cancer progression under normoxic and hypoxic conditions. Particularly, the sustained stimulation of epidermal growth factor receptor (EGFR), insulin‐like growth factor‐1 receptor (IGF‐1R), stem cell factor (SCF) receptor KIT, transforming growth factor‐β receptors (TGF‐βRs) and N otch and their downstream signalling elements such as phosphatidylinositol 3′‐kinase (PI3K)/Akt/molecular target of rapamycin (mTOR) may lead to an enhanced activity of HIFs. Moreover, the up‐regulation of HIFs in cancer cells may also occur in the hypoxic intratumoral regions formed within primary and secondary neoplasms as well as in leukaemic cells and metastatic prostate and breast cancer cells homing in the hypoxic endosteal niche of bone marrow. The activated HIFs may induce the expression of numerous gene products such as induced pluripotency‐associated transcription factors (Oct‐3/4, Nanog and Sox‐2), glycolysis‐ and epithelial‐mesenchymal transition (EMT) programme‐associated molecules, including CXC chemokine receptor 4 (CXCR4), snail and twist, micro RNA s and angiogenic factors such as vascular endothelial growth factor (VEGF). These gene products in turn can play critical roles for high self‐renewal ability, survival, altered energy metabolism, invasion and metastases of cancer cells, angiogenic switch and treatment resistance. Consequently, the targeting of HIF signalling network and altered metabolic pathways represents new promising strategies to eradicate the total mass of cancer cells and improve the efficacy of current therapies against aggressive and metastatic cancers and prevent disease relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–290 of 290
Cheng, Z., Sun, B., Wang, S., Gao, Y., Zhang, Y., Zhou, H., Jia, G., Wang, Y., Kong, R., Pan, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023752 · Cited by 91
Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24- breast cancer cells
Phuc, P. V., Phan, N. L.-C., Nhung, T. H., Tâm, N. T., Hoang, N. M., Tue, V. G., Thuy, D. T., & Ngoc, P. K. (2011) · OncoTargets and Therapy · doi:10.2147/ott.s21431 · Cited by 90
Cho, S., Lee, H., Jeong, S., Lee, H., Kim, H., Chen, C. Y., Lee, E., & Kim, S. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00865.x · Cited by 89
Efficient Elimination of Cancer Cells by Deoxyglucose-ABT-263/737 Combination Therapy
Yamaguchi, R., Janssen, E. M., Perkins, G. A., Ellisman, M. H., Kitada, S., & Reed, J. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024102 · Cited by 85
Chhipa, R. R., Wu, Y., & Ip, C. C. Y. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.04.008 · Cited by 83
Impact of Hypoxia on the Metastatic Potential of Human Prostate Cancer Cells
Dai, Y., Bae, K., & Siemann, D. W. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.04.027 · Cited by 83
Cao, X., Bloomston, M., Zhang, T., Frankel, W. L., Jia, G., Wang, B., Hall, N. C., Koch, R. M., Cheng, H., Knopp, M. V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1607 · Cited by 83
Ruas, J. L., Berchner‐Pfannschmidt, U., Malik, S., Gradin, K., Fandrey, J., Roeder, R. G., Pereira, T., & Poellinger, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021824 · Cited by 82
Yin, S., Kaluz, Š., Devi, N. S., Jabbar, A. A., de Noronha, R. G., Mun, J.-Y., Zhang, Z., Boreddy, P. R., Wang, W., Wang, Z., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0861 · Cited by 80
Partch, C. L., & Gardner, K. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101357108 · Cited by 76
CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration
Braig, S., Wallner, S., Junglas, B., Fuchshofer, R., & Bosserhoff, A. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.226 · Cited by 75
CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro
Krohn, A., Song, Y., Muehlberg, F. L., Droll, L. H., Beckmann, C., & Alt, E. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.005 · Cited by 75
Sivridis, E., Koukourakis, M. I., Mendrinos, S. E., Karpouzis, A., Fiska, A., Kouskoukis, C., & Giatromanolaki, A. (2011) · Melanoma Research · doi:10.1097/cmr.0b013e328346612c · Cited by 73
Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype
Annabi, B., Rojas‐Sutterlin, S., Laflamme, C., Lachambre, M., Rolland, Y., Sartelet, H., & Béliveau, R. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2184 · Cited by 72
Hasmim, M., Noman, M. Z., Lauriol, J., Benlalam, H., Mallavialle, A., Rosselli, F., Mami‐Chouaib, F., Alcaïde‐Loridan, C., & Chouaïb, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101011 · Cited by 71
Mitani, T., Yamaji, R., Higashimura, Y., Harada, N., Nakano, Y., & Inui, H. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.10.009 · Cited by 65
Bendinelli, P., Matteucci, E., Maroni, P., & Desiderio, M. A. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0548 · Cited by 64
Partch, C. L., & Gardner, K. H. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22067 · Cited by 63
Mimeault, M., & Batra, S. K. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00115 · Cited by 62
Self-citationOnozuka, H., Tsuchihara, K., & Esumi, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01880.x · Cited by 61
Chun, Y. S., Lee, K. H., Choi, E., Bae, S. Y., Yeo, E. J., Huang, E. L., Kim, M., & Park, J.-W. (2003) · PubMed · Cited by 61
Bhardwaj, V., Rizvi, N., Lai, M. B., Lai, J. C. K., & Bhushan, A. (2010) · PubMed · Cited by 61
Inhibition of stromal CXCR4 impairs development of lung metastases
D’Alterio, C., Barbieri, A., Portella, L., Palma, G., Polimeno, M., Riccio, A., Ieranò, C., Franco, R., Scognamiglio, G., Bryce, J., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1223-7 · Cited by 60
Mimeault, M., Johansson, S. L., Hénichart, J., Depreux, P., & Batra, S. K. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1013 · Cited by 58
Self-citationMimeault, M., & Batra, S. K. (2010) · PubMed · doi:10.14670/hh-25.1057 · Cited by 56
Self-citationPotential for Cripto-1 in defining stem cell-like characteristics in human malignant melanoma
Strizzi, L., Abbott, D. E., Salomon, D. S., & Hendrix, M. J. C. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6236 · Cited by 55
Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions
Chae, K. S., Kang, M. J., Lee, J., Ryu, B. K., Lee, M. G., Her, N.-G., Ha, T. K., Han, J., Kim, Y. K., & G, S. (2010) · Oncogene · doi:10.1038/onc.2010.498 · Cited by 54
Tu, S. M., & Lin, S.-H. (2012) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2012.01.002 · Cited by 52
Role of endothelial nitric oxide synthase (eNOS) in chronic stress‐promoted tumour growth
Barbieri, A., Palma, G., Rosati, A., Giudice, A., Falco, A., Petrillo, A., Petrillo, M., Bimonte, S., Benedetto, M. D., Esposito, G., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01375.x · Cited by 52
Hu, H., Chai, Y., Wang, L., Zhang, J., Lee, H., Kim, S., & Lü, J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0288 · Cited by 52
Giuntoli, S., Tanturli, M., Gesualdo, F. D., Barbetti, V., Rovida, E., & Sbarba, P. D. (2010) · Haematologica · doi:10.3324/haematol.2010.029082 · Cited by 50
Mizuno, T., Nagao, M., Yamada, Y., Narikiyo, M., Ueno, M., Miyagishi, M., Taira, K., & Nakajima, Y. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700871 · Cited by 49
Mimeault, M., Johansson, S. L., & Batra, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031919 · Cited by 49
Self-citationMimeault, M., & Batra, S. K. (2008) · Gut · doi:10.1136/gut.2008.150052 · Cited by 49
Self-citationBaker, L. C. J., Boult, J. K. R., Walker‐Samuel, S., Chung, Y.-L., Jamin, Y., Ashcroft, M. A., & Robinson, S. P. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.131 · Cited by 48
Exposure to hypoxia following irradiation increases radioresistance in prostate cancer cells
Hennessey, D. B., Martin, L. M., Atzberger, A., Lynch, T. H., Hollywood, D. P., & Marignol, L. H. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.10.008 · Cited by 47
Li-jun, L. I. N. G., Wang, S., Liu, X., En-chao, S. H. E. N., Ding, Q., Lü, C., Xu, J. Y., Qin-hong, C. A. O., Hai-qing, Z. H. U., & Wang, F. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200810020-00006 · Cited by 46
FTS and 2-DG induce pancreatic cancer cell death and tumor shrinkage in mice
Goldberg, L., Israeli, R., & Kloog, Y. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.24 · Cited by 45
Zhang, M., Ma, Q., Hu, H., Zhang, D., Li, J., Ma, G., Bhat, K., & Wu, E. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.017 · Cited by 45
Onishi, H., Morifuji, Y., Kai, M., Suyama, K., Iwasaki, H., & Katano, M. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02297.x · Cited by 45
Azzariti, A., Porcelli, L., Gatti, G., Nicolin, A., & Paradiso, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.018 · Cited by 45
New promising drug targets in cancer- and metastasis-initiating cells
Mimeault, M., & Batra, S. K. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.009 · Cited by 44
Self-citationIbáñez, E., Agliano, A., Prior, C., Nguewa, P., Redrado, M., Zubeldia, I. G., Plano, D., Palop, J. A., Sanmartín, C., & Calvo, A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800672076 · Cited by 44
Saigusa, S., Tanaka, K., Toiyama, Y., Yokoe, T., Okugawa, Y., Koike, Y., Fujikawa, H., Inoue, Y., Miki, C., & Kusunoki, M. (2010) · Clinical Oncology · doi:10.1016/j.clon.2010.09.012 · Cited by 43
Joseph, J., Shiozawa, Y., Jung, Y., Kim, J. K., Pedersen, E. A., Mishra, A., Zalucha, J. L., Wang, J., Keller, E. T., Pienta, K. J., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0404 · Cited by 43
Low oxygen levels induce the expression of the embryonic morphogen Nodal
Quail, D. F., Taylor, M. J., Walsh, L. A., Dieters‐Castator, D. Z., Das, P., Jewer, M., Zhang, G., & Postovit, L.-M. M. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-03-0263 · Cited by 42
Rakicidin A effectively induces apoptosis in hypoxia adapted Bcr‐Abl positive leukemic cells
Takeuchi, M., Ashihara, E., Yamazaki, Y. M., Kimura, S. H., Nakagawa, Y., Tanaka, R., Yao, H., Nagao, R., Hayashi, Y., Hirai, H., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01813.x · Cited by 41
Wang, Z., Shi, Q., Wang, Z., Gu, Y., Shen, Y., Sun, M.-M., Deng, M., Zhang, H., Junchu, F., Zhang, S., et al. (2011) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.06.009 · Cited by 41
Takeuchi, M., Kimura, S. H., Kuroda, J., Ashihara, E., Kawatani, M., Osada, H., Umezawa, K., Yasui, E., Imoto, M., TSURUO, T., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.6 · Cited by 40
HIF-1α links β-adrenoceptor agonists and pancreatic cancer cells under normoxic condition
Hu, H.-T., Ma, Q.-Y., Zhang, D., Shen, S.-G., Han, L., Ma, Y.-D., Li, R.-F., & Xie, K.-P. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.181 · Cited by 39
Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas
Mimeault, M., & Batra, S. K. (2012) · World Journal of Clinical Oncology · doi:10.5306/wjco.v3.i3.32 · Cited by 39
Self-citationHypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer
Kasuya, K. (2011) · Oncology Reports · doi:10.3892/or.2011.1457 · Cited by 39
Mimeault, M., & Batra, S. K. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00885.x · Cited by 38
Self-citationKawakami, K., Hattori, M., Inoue, T., Maruyama, Y., Ohkanda, J., Kato, N., Tongu, M., Yamada, T., Akimoto, M., Takenaga, K., et al. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012802650264 · Cited by 37
Kim, E. J.-H., & Simeone, D. M. (2011) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328349e31f · Cited by 37
Pioglitazone modulates tumor cell metabolism and proliferation in multicellular tumor spheroids
Gottfried, E., Rogenhofer, S., Waibel, H., Kunz‐Schughart, L. A., Reichle, A., Wehrstein, M., Peuker, A., Peter, K., Hartmannsgruber, G., Andreesen, R., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1294-0 · Cited by 35
Methylseleninic acid downregulates hypoxia‐inducible factor‐1α in invasive prostate cancer
Sinha, I., Null, K., Wolter, W., Suckow, M. A., King, T. S., Pinto, J. T., & Sinha, R. (2011) · International Journal of Cancer · doi:10.1002/ijc.26141 · Cited by 34
Yamasaki, M., Nomura, T., Sato, F., & Mimata, H. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.12.007 · Cited by 33
Combined treatment targeting HIF‐1α and Stat3 is a potent strategy for prostate cancer therapy
Reddy, K. R., Guan, Y., Qin, G., Zhou, Z., & Jing, N. (2011) · The Prostate · doi:10.1002/pros.21397 · Cited by 32
Prognostic relevance of hypoxia inducible factor-1α expression in patients with melanoma
Valencak, J., Kittler, H., Schmid, K., Schreiber, M., Raderer, M., Inchaurraga, M. A. G., Birner, P., & Pehamberger, H. (2009) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2009.03706.x · Cited by 32
Staab, A., Fleischer, M., Loeffler, J., Said, H. M., Katzer, A., Plathow, C., Einsele, H., Flentje, M. P., & Vordermark, D. (2011) · Strahlentherapie und Onkologie · doi:10.1007/s00066-011-2167-0 · Cited by 31
Mimeault, M., & Batra, S. K. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00505.x · Cited by 30
Self-citationLiposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Hagtvet, E., Redalen, K. R., & Olsen, D. R. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-135 · Cited by 29
Zhang, L., & Hill, R. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4221 · Cited by 28
Jing, S., Wang, Y. D., Chen, L.-Q., Sang, M., Zheng, M., Sun, G. G., Qianyun, L. I. U., Cheng, Y. J., & Yang, C.-R. (2012) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2011.01321.x · Cited by 27
Castration Therapy of Prostate Cancer Results in Downregulation of HIF-1α Levels
Al-Ubaidi, F. L. T., Schultz, N., Egevad, L., Granfors, T., & Helleday, T. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.10.038 · Cited by 27
Mimeault, M., & Batra, S. K. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.03.001 · Cited by 26
Self-citationG-rich Oligonucleotides Inhibit HIF-1α and HIF-2α and Block Tumor Growth
Guan, Y., Reddy, K. R., Zhu, Q., Li, Y., Lee, K., Weerasinghe, P., Prchal, J. T., Semenza, G. L., & Jing, N. (2009) · Molecular Therapy · doi:10.1038/mt.2009.219 · Cited by 26
Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas
Oliveira–Costa, J. P., Zanetti, J. S., da Silveira, G. G., Soave, D. F., Oliveira, L. R., Zorgetto-Pinheiro, V. A., Soares, F. A., Zucoloto, S., & Ribeiro‐Silva, A. (2011) · Diagnostic Pathology · doi:10.1186/1746-1596-6-73 · Cited by 26
Huang, Y., Yu, J., Yan, C.-Y., Hou, J., Pu, J., Zhang, G., Fu, Z., & Wang, X. (2011) · Urology · doi:10.1016/j.urology.2011.10.024 · Cited by 25
Wei, H., Wang, C., & Chen, L. (2006) · Pancreas · doi:10.1097/01.mpa.0000202961.71600.9b · Cited by 25
Gibbs, B. F., Yasinska, I. M., Oniku, A. E., & Sumbayev, V. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022502 · Cited by 24
Nagao, R., Ashihara, E., Kimura, S. H., Strovel, J. W., Yao, H., Takeuchi, M., Tanaka, R., Hayashi, Y., Hirai, H., Padia, J. K., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.002 · Cited by 23
Manohar, S. M., Padgaonkar, A., Jalota‐Badhwar, A., Sonawane, V. R., Rathos, M. J., Kumar, S., & Joshi, K. S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-338 · Cited by 22
Manohar, S. M., Padgaonkar, A., Jalota‐Badhwar, A., Rao, S. V., & Joshi, K. S. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.51 · Cited by 22
Ellis, L., Lehet, K., Ramakrishnan, S., Adelaiye-Ogala, R. M., Miles, K. M., Wang, D., Liu, S., Atadja, P. W., Carducci, M. A., & Пили, Р. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027178 · Cited by 19
Chen, B., Sun, Y., & Ni, J. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0724-3 · Cited by 19
Targeting Cancer Stem Cell Lines as a New Treatment of Human Cancer
Giuffrida, D., & Rogers, I. M. (2010) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489210791760535 · Cited by 17
Schoolmeesters, A., Brown, D. D., & Federov, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031270 · Cited by 17
Trevino-Villarreal, J. H., Cotanche, D. A., Sepúlveda, R., Bortoni, M. E., Manneberg, O., Udagawa, T., & Rogers, R. A. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411428078 · Cited by 16
Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models.
Tonra, J. R., Corcoran, E., Deevi, D. S., Steiner, P., Kearney, J. A., Li, H., Ludwig, D. L., Zhu, Z., Witte, L., Surguladze, D., et al. (2009) · PubMed · Cited by 14
Ling, L., Wang, S., Liu, X., Shen, E., Ding, Q., Lu, C., Xu, J., Cao, Q., Zhu, H., & Wang, F. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-4155 · Cited by 14
Suppression of autophagy by BCR/ABL
Calabretta, B., & Salomoni, P. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/278 · Cited by 14
Antimetastatic activity of MONCPT in preclinical melanoma mice model
Yang, X., Tu, C., Luo, P., Zhu, H., Zhu, D., Wu, H., Zhou, X., Lu, W. P., He, Q., & Yang, B. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9323-8 · Cited by 12
The Role of Hypoxia-Inducible Factor-1α and -2α in Androgen Insensitive Prostate Cancer Cells
Jeong, C. W., Yoon, C. Y., Jeong, S. J., Hong, S. K., Byun, S., Kwak, C. H., & Lee, S. E. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.03.022 · Cited by 11
Shaida, N., Chan, P., Turley, H., Jones, C. M., Kanga, S., Ritchie, R. W., Malone, P. R., Harris, A. L., & Fox, S. B. (2011) · The Journal of Urology · doi:10.1016/j.juro.2010.12.001 · Cited by 10
Johansson, A., Rudolfsson, S. H., Kilter, S., & Bergh, A. R. J. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09690.x · Cited by 10
The effect of normoxia and hypoxia on a prostate (PC-3) CD44/CD41 cell side fraction.
Anderson, K. M., Guinan, P., & Rubenstein, M. (2011) · PubMed · Cited by 9
Cheng, B.-Q., Segersvärd, R., Permert, J., & Wang, F. (2010) · European Surgical Research · doi:10.1159/000319876 · Cited by 4
Hedgehog signaling and desmoplasia are regulated by hypoxia in pancreatic cancer
Spivak-Kroizman, T. R., Hostetter, G. H., Hoff, D. D. V., Posner, R. G., Abdelmelek, M. F., James, B. P., Demeure, M. J., & Powis, G. (2010) · Clinical Cancer Research · doi:10.1158/diag-10-pr11 · Cited by 1
Cited by
Goel, H. L., & Mercurio, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3627 · Cited by 1,253
Anoikis molecular pathways and its role in cancer progression
Paoli, P., Giannoni, E., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.026 · Cited by 1,160
Emami Nejad, A., Najafgholian, S., Rostami, A., Sistani, A., Shojaeifar, S., Esparvarinha, M., Nedaeinia, R., Haghjooy Javanmard, S., Taherian, M., Ahmadlou, M., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01719-5 · Cited by 693
Targeting the TGFβ pathway for cancer therapy
Neuzillet, C., Tijeras-Raballand, A., Cohen, R., Cros, J., Faivre, S., Raymond, E., & de Gramont, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.001 · Cited by 611
HIF‐1 at the crossroads of hypoxia, inflammation, and cancer
Balamurugan, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.29519 · Cited by 572
Metadata
- Authors
- Mimeault, M., & Batra, S. K.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2013-01
- Volume
- 17
- Issue
- 1
- Pages
- 30-54
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W2026601790
- Cited by
- 330
- References
- 290
- FWCI
- 12.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.